Paper3357070
Staging and prognosis of chronic lymphocytic leukemia: the Manitoba experience.
MacDougall BK and 1 other. J Gen Intern Med, 1988. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Staging and prognosis of chronic lymphocytic leukemia: the Manitoba experience. Papers, record 3357070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3357070
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Lymphoid | Major topic |
| Female | |
| Humans | |
| Male | |
| Manitoba | |
| Neoplasm Staging | |
| Prognosis | |
| Registries | |
| Retrospective Studies |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7139586 | Chronic lymphocytic leukemia. A review of 745 cases and assessment of clinical staging. | Cancer | 1982 | https://conductscience.org/library/papers/7139586 | PubMed |
| 2 | 7237385 | A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. | Cancer | 1981 | https://conductscience.org/library/papers/7237385 | PubMed |
| 3 | 7005681 | Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. | N Engl J Med | 1981 | https://conductscience.org/library/papers/7005681 | PubMed |
| 4 | 1062691 | Second neoplasms with chronic lymphocytic leukemia. | N Y State J Med | 1976 | https://conductscience.org/library/papers/1062691 | PubMed |
| 5 | 7259986 | Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL. | Br J Haematol | 1981 | https://conductscience.org/library/papers/7259986 | PubMed |
| 6 | 5229351 | The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. | J Natl Cancer Inst | 1967 | https://conductscience.org/library/papers/5229351 | PubMed |
| 7 | 1139039 | Clinical staging of chronic lymphocytic leukemia. | Blood | 1975 | https://conductscience.org/library/papers/1139039 | PubMed |
| 8 | 14254069 | LEUKEMIA AND CANCER IN THE SAME PATIENT. | Cancer | 1965 | https://conductscience.org/library/papers/14254069 | PubMed |
| 9 | 2872470 | Effectiveness of "CHOP" regimen in advanced untreated chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia. | Lancet | 1986 | https://conductscience.org/library/papers/2872470 | PubMed |
| 10 | 334410 | Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy. | Clin Haematol | 1977 | https://conductscience.org/library/papers/334410 | PubMed |
| 11 | 5451217 | Chronic lymphocytic leukemia and subsequent cancer in the same patient. | Cancer | 1970 | https://conductscience.org/library/papers/5451217 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3357070
GET https://conductscience.org/api/papers/v1/3357070/authors